| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lymphocyte activating 3 | 0.517 | 0.692 | 0.28 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2019 | ||||||||
|
neural precursor cell expressed, developmentally down-regulated 9 | 0.548 | 0.769 | 0.13 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 1989 | 1991 | ||||||||
|
SCY1 like pseudokinase 1 | 0.582 | 0.769 | 2.5E-08 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 1989 | 1991 | ||||||||
|
peptidylprolyl isomerase G | 0.497 | 0.846 | 0.96 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2012 | 2015 | ||||||||
|
DCC netrin 1 receptor | 0.471 | 0.808 | 0.99 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 1995 | 2015 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2007 | 2019 | ||||||||
|
Fc fragment of IgG receptor IIIa | 0.432 | 0.962 | 3.7E-06 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2001 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2001 | 2013 | ||||||||
|
programmed cell death 2 | 0.700 | 0.423 | 3.9E-07 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2003 | 2010 | ||||||||
|
granzyme B | 0.453 | 0.808 | 3.7E-14 |
|
group | 0.080 | None | 0.750 | 8 | 0 | 1995 | 2018 | ||||||||
|
KLRC4-KLRK1 readthrough | 0.469 | 0.769 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2011 | 2018 | |||||||||
|
killer cell lectin like receptor K1 | 0.467 | 0.769 | 7.0E-14 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2011 | 2018 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2016 | 2018 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase | 0.482 | 0.808 | 2.4E-12 |
|
group | 0.330 | None | 0.750 | 4 | 1 | 2004 | 2017 | ||||||||
|
caspase 2 | 0.565 | 0.731 | 1.5E-03 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2012 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.050 | None | 0.800 | 5 | 0 | 2000 | 2015 | ||||||||
|
H2A.X variant histone | 0.484 | 0.808 | 0.18 |
|
group | 0.050 | None | 0.800 | 5 | 0 | 2003 | 2009 | ||||||||
|
TIA1 cytotoxic granule associated RNA binding protein | 0.595 | 0.577 | 0.27 |
|
group | 0.050 | None | 0.800 | 5 | 0 | 1995 | 2004 | ||||||||
|
calcium and integrin binding 1 | 0.458 | 0.769 | 3.3E-04 |
|
group | 0.060 | None | 0.833 | 6 | 0 | 2001 | 2009 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.060 | None | 0.833 | 6 | 0 | 2009 | 2019 | ||||||||
|
SRY-box transcription factor 11 | 0.494 | 0.808 | 0.86 |
|
group | 0.060 | None | 0.833 | 6 | 0 | 2008 | 2018 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
group | 0.060 | None | 0.833 | 6 | 0 | 1998 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.070 | None | 0.857 | 7 | 0 | 2002 | 2019 | ||||||||
|
SH2 domain containing 1A | 0.525 | 0.731 | 0.39 |
|
group | 0.470 | strong | 0.857 | 7 | 0 | 1998 | 2019 | ||||||||
|
REL proto-oncogene, NF-kB subunit | 0.579 | 0.692 | 1.00 |
|
group | 0.070 | None | 0.857 | 7 | 0 | 2003 | 2015 |